Neurobehavioral Disorders

Latest News

FDA to Review Manipulation-Resistant Stimulant Medication for ADHD

AR19 is an investigational immediate-release, amphetamine formulated to prevent the manipulation of the pellets in the capsules for nonmedical use.

Spinal Cord Injury Associated With Increased Incidence of Psychiatric Morbidity

Compared with adults without SCI, adults with traumatic SCI have an increased incidence of psychological morbidities and multimorbidity.

Loneliness, Sleep Trouble May Raise Risk for Depression and Anxiety Among Adults With Intellectual Disabilities

Depression and anxiety were significantly associated with sleep difficulties, including trouble falling asleep, early waking, coughing or snoring, feeling too cold or too hot, and having a bad dream.

Antidepressant Trials Often Exclude Patients Displaying Suicidality, Study Finds

Of all the antidepressant efficacy trials conducted between 1991 and 2013, just 1 explicitly included patients who presented with suicidality.

Sedentary Behavior Linked to Increased Risk for Depression in Older Adults

Investigators found data that showed longer sedentary time frames correlated with increased risk for depression in older patients.

Discontinuation of Dolutegravir Due to Neurologic Side Effects Linked to Pre-Existing Mental Illness

Dolutegravir (DTG) discontinuation due to neuropsychologic side effects (NPS) may be associated with pre-existing psychiatric conditions of depression and anxiety.

Frontal Lobe Dysfunction and Repetitive Transcranial Magnetic Stimulation in Depression

The study compared improvements in frontal lobe dysfunction induced by rTMS and improvement of white matter integrity revealed by diffusion tensor imaging in patients with TRD receiving rTMS treatment.

In the Presence of a Sleep Disturbance, Stressful Life Events Increase Risk for Anxiety and Depression

Researchers examined how the associations of life event stress with impulsivity, anxiety, and depressed mood change in the presence of sleep disturbance.

Gut Microbiota Can Drive Neuroinflammation in Major Depressive Disorder

The influence of gut microbiota extends to the brain via neuroinflammation, resulting in symptoms associated with major depressive disorder.

Antipsychotics Linked to Adverse Changes in Brain Structure

Patients with psychotic depression who experienced an illness relapse while receiving placebo also had a decline in cortical thickness, emphasizing the essential role antipsychotics play in treating disorders where psychosis is present.